Indane derivatives for use in the treatment of bacterial infection
The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; heb |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Simon LEIRIS Richard Leonard ELLIOTT David Edward CLARK THOMAS DAVID PALLIN David Thomas DAVIES Martin EVERETT Lilha BEYRIA Nicolas SPRYNSKI Toby Jonathan BLENCH Andrew Peter CRIDLAND |
description | The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL281780A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL281780A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL281780A3</originalsourceid><addsrcrecordid>eNrjZHDyzEtJzEtVSEktyixLLMksSy1WSMsvUigtTlXIzFMoyUhVKClKTSzJTc0rUchPU0hKTC4BKk3MAcqmpSaXZObn8TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeE8fIwtDcwsDR2OCCgAS_DDP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Indane derivatives for use in the treatment of bacterial infection</title><source>esp@cenet</source><creator>Simon LEIRIS ; Richard Leonard ELLIOTT ; David Edward CLARK ; THOMAS DAVID PALLIN ; David Thomas DAVIES ; Martin EVERETT ; Lilha BEYRIA ; Nicolas SPRYNSKI ; Toby Jonathan BLENCH ; Andrew Peter CRIDLAND</creator><creatorcontrib>Simon LEIRIS ; Richard Leonard ELLIOTT ; David Edward CLARK ; THOMAS DAVID PALLIN ; David Thomas DAVIES ; Martin EVERETT ; Lilha BEYRIA ; Nicolas SPRYNSKI ; Toby Jonathan BLENCH ; Andrew Peter CRIDLAND</creatorcontrib><description>The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.</description><language>eng ; heb</language><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210531&DB=EPODOC&CC=IL&NR=281780A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210531&DB=EPODOC&CC=IL&NR=281780A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Simon LEIRIS</creatorcontrib><creatorcontrib>Richard Leonard ELLIOTT</creatorcontrib><creatorcontrib>David Edward CLARK</creatorcontrib><creatorcontrib>THOMAS DAVID PALLIN</creatorcontrib><creatorcontrib>David Thomas DAVIES</creatorcontrib><creatorcontrib>Martin EVERETT</creatorcontrib><creatorcontrib>Lilha BEYRIA</creatorcontrib><creatorcontrib>Nicolas SPRYNSKI</creatorcontrib><creatorcontrib>Toby Jonathan BLENCH</creatorcontrib><creatorcontrib>Andrew Peter CRIDLAND</creatorcontrib><title>Indane derivatives for use in the treatment of bacterial infection</title><description>The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDyzEtJzEtVSEktyixLLMksSy1WSMsvUigtTlXIzFMoyUhVKClKTSzJTc0rUchPU0hKTC4BKk3MAcqmpSaXZObn8TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeE8fIwtDcwsDR2OCCgAS_DDP</recordid><startdate>20210531</startdate><enddate>20210531</enddate><creator>Simon LEIRIS</creator><creator>Richard Leonard ELLIOTT</creator><creator>David Edward CLARK</creator><creator>THOMAS DAVID PALLIN</creator><creator>David Thomas DAVIES</creator><creator>Martin EVERETT</creator><creator>Lilha BEYRIA</creator><creator>Nicolas SPRYNSKI</creator><creator>Toby Jonathan BLENCH</creator><creator>Andrew Peter CRIDLAND</creator><scope>EVB</scope></search><sort><creationdate>20210531</creationdate><title>Indane derivatives for use in the treatment of bacterial infection</title><author>Simon LEIRIS ; Richard Leonard ELLIOTT ; David Edward CLARK ; THOMAS DAVID PALLIN ; David Thomas DAVIES ; Martin EVERETT ; Lilha BEYRIA ; Nicolas SPRYNSKI ; Toby Jonathan BLENCH ; Andrew Peter CRIDLAND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL281780A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Simon LEIRIS</creatorcontrib><creatorcontrib>Richard Leonard ELLIOTT</creatorcontrib><creatorcontrib>David Edward CLARK</creatorcontrib><creatorcontrib>THOMAS DAVID PALLIN</creatorcontrib><creatorcontrib>David Thomas DAVIES</creatorcontrib><creatorcontrib>Martin EVERETT</creatorcontrib><creatorcontrib>Lilha BEYRIA</creatorcontrib><creatorcontrib>Nicolas SPRYNSKI</creatorcontrib><creatorcontrib>Toby Jonathan BLENCH</creatorcontrib><creatorcontrib>Andrew Peter CRIDLAND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Simon LEIRIS</au><au>Richard Leonard ELLIOTT</au><au>David Edward CLARK</au><au>THOMAS DAVID PALLIN</au><au>David Thomas DAVIES</au><au>Martin EVERETT</au><au>Lilha BEYRIA</au><au>Nicolas SPRYNSKI</au><au>Toby Jonathan BLENCH</au><au>Andrew Peter CRIDLAND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Indane derivatives for use in the treatment of bacterial infection</title><date>2021-05-31</date><risdate>2021</risdate><abstract>The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, L, n and p are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; heb |
recordid | cdi_epo_espacenet_IL281780A |
source | esp@cenet |
title | Indane derivatives for use in the treatment of bacterial infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A21%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Simon%20LEIRIS&rft.date=2021-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL281780A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |